ITI News Archive
Stanford Medicine News
-
William Robinson, pioneering virologist
Hard-driving molecular virologist who used ‘advanced chemistry to unlock the tightly held secrets of viruses’ was also a hearty mountain man, scaling peaks in Alaska and Nepal.
-
Screening for chronic kidney disease
Many people don’t know they have chronic kidney disease until it progresses. A new study by Stanford Medicine researchers finds that screening would increase life expectancy in a cost-effective way.
-
Beating-heart transplant
Surgeons at Stanford Medicine believe the new technique, which has now been performed on six patients, will improve health outcomes for recipients and boost the pool of available organs.
-
New COVID-19 vaccine
In a study led by Stanford Medicine researchers, a low-cost COVID-19 vaccine that does not require refrigeration provided immunity in rhesus monkeys for one year.
-
First abdominal wall transplant in state
The 22-year-old patient had waited years for an intestinal transplant. At Stanford Medicine, a combined intestinal and abdominal wall transplant gave him an even better option.
-
mRNA vaccine beats infection
Stanford Medicine researchers have shown that prior SARS-CoV-2 infection reduces killer T cells’ response to vaccination. These cells are crucial for eliminating the virus from the body.
-
Osteoarthritis linked to allergic inflammation
A connection found between asthma, eczema and osteoarthritis indicates that drugs to treat allergic conditions could be used in future studies aimed at slowing the progression of osteoarthritis.
-
Myc-caused sugar changes protect cancers
A novel Stanford School of Medicine partnership uncovers a direct link between a cancer-associated gene, Myc, and sugar patterns on cancer cell surfaces that tell immune cells to stand down.
-
Long-COVID clinical trials underway
Developing the right treatment for long COVID depends on figuring out what’s causing it. Stanford Medicine researchers are bent on learning more about the people who have it to find out.
-
Cancer cells become cancer cure
Researchers found that when they turned cancer cells into immune cells, they were able to teach other immune cells how to attack cancer.